Pharmacia Diagnostics Worldwide manufactures and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. Some 98 percent of production is exported to more than 3000 laboratories in 60 countries. Supplying seven out of ten allergy laboratory tests worldwide, the company has remained the world leader in its field for more than 25 years.
Pharmacia Diagnostics has more than 30 years experience in the field of atopic disease including significant research development initiatives and successful introductions of products for the diagnosis of atopic disease.
Now UniCAP brings you a trustworthy diagnostic system with levels of convenience and flexibility. The UniCAP in vitro immunoassay system is fast, fully integrated, automated as well as offering a superb analyte panel. The new generation of immunoreagents has been improved for faster reaction time and higher precision. The consistently temperature controlled UniCAP environment ensures optimal diagnostic precision and reproducibility.
UniCAP lets you complete up to 48 different determinations from among 500 different allergens, complete with automatic documentation in less than 3 hours.
What does this mean for you and your patients?
ImmunoCAP technology is 4-5 times more sensitive than RAST testing.
Simple, comfortable, and safe, with no fear of anaphylaxis.
Not necessary to stop medication, such as antihistamines.
Offers an alternative to other methods of allergy testing.
Pharmacia Diagnostics joined the field of Autoimmunity with the acquisition of German based Elias, which manufactures ELISA kits for the differential diagnostic of autoimmune related diseases. From an ANA screen of 11 antigens to single parameter capacity. The Pharmacia autoimmune diagnostic kits will be an invaluable tool for doctors and health care professionals. Pharmacia Diagnostics offers worldwide more than 30 autoantibody tests based on the Varelisa microplate format. The eukaryotic Baculovirus System for the production of our antigens ensures the correct antigen conformation corresponding to native counterpart in human tissue. The use of these human recombinant antigens guarantees outstanding assay performance. The future for the Autoimmunity products looks promising as all of the parameters available on the ELISA format will become available for the UniCAP system, thus rendering Autoimmunity diagnostic a fully automated process.
Collaboration with clinical and researchers
Through seminars, symposia and meetings with clinicians and researchers, the clinical need and utility of in vitro tests have been defined and clarified. Intensive collaboration with the world’s research community of the cornerstone of the company. An example of the commitment is the annual Pharmacia Research Foundation award to outstanding young researchers for contributions and continued research in areas of allergy and inflammation.
Pharmacia Diagnostics continues to develop laboratory assays in allergy, asthma, autoimmunity and other defined clinical areas.